ORTEXORTEX News
Tracking CPT? Get live short interest, options flow, and signals on ORTEX.Sign up free →
CP
Earnings PreviewCPT

Camden Property Trust Faces Analyst Downgrades Before Q3 Print

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 26 Oct 2026, 04:00

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Camden Property Trust reports Q3 results on October 29 against a backdrop of coordinated analyst target cuts and options positioning that has pulled back sharply from last week's extremes.

The options story has shifted since the previous ORTEX note on October 20, when the put/call ratio reached 1.77 and a z-score above four. The PCR has since eased to 1.44, still above its 20-day average of 0.90 but no longer at a near-52-week extreme. That normalisation follows a week in which CPT gained 3.5%, broadly in line with peers: MAA rose 2.7%, UDR 4.6%, and ESS 3.3% over the same period. Put demand has cooled, but it has not reversed.

The more durable pressure point is analyst sentiment. Seven firms cut their price targets in the two weeks before the print, all while maintaining neutral-to-underweight ratings. Wells Fargo trimmed to $103 and Evercore ISI to $108, both on October 19. UBS moved to $101 and RBC Capital to $101 on October 14. Piper Sandler made the steepest revision, dropping its target from $119 to $102. The consensus mean now sits at $111, against a current price of $102, leaving implied upside modest but the direction of travel clearly downward. None of the recent movers added a buy rating.

The disagreement among observers centres on the rate environment and what it means for Camden's development book. The bull case rests on a low-leverage balance sheet, April occupancy of 95.4%, reiterated 2026 core FFO guidance of $6.60 to $6.90 per share, and the argument that Sun Belt supply headwinds are peaking. The bear case points to refinancing costs that are compressing earnings growth, 2026 FFO expected around $6.05 to $6.11 per share on a reported basis, and only marginal SSNOI growth in 2027. Expense growth of 3.2% to 3.6% running against revenue growth of 1.2% to 1.4% is the arithmetic that keeps the bearish argument alive.

Short interest has risen roughly 12% over the past month to 4.5% of free float, a modest build rather than an aggressive conviction bet. The borrow market is essentially unconstrained, with availability at nearly 7,900% of short interest and cost to borrow under 0.5%. BlackRock added 573,618 shares in the most recent filing period to hold 10.4% of shares, while FMR lifted its stake to 7%. The ownership base is index-heavy and stable, which limits the potential for forced selling to amplify any earnings-driven move.

The October 29 print will test whether Camden's management can defend the top end of its FFO guidance range in an environment where seven of its own analysts have already moved their targets toward the current share price.

Stocks in this article

See the live data behind this article on ORTEX.

Open CPT on ORTEX →

How this article was generated

Generated
26 Oct 2026, 04:06
Data as of
26 Oct 2026, 04:00
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.